LAMP2 and infection: Other authors also showed that inhibition of endocytosis processes, when cells are treated with the dynamin inhibitor, dynasore (Barrias et al., 2010) or in the case of LAMP-2 lacking cells where caveolin-dependent endocytosis is impaired (Couto et al., 2017), leads to a reduction on the infection.